- Home
- CRVS vs IHRT Comparison
CRVS vs IHRT Comparison
Compare CRVS & IHRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRVS
- IHRT
- Stock Information
- Founded
- CRVS 2014
- IHRT 1974
- Country
- CRVS United States
- IHRT United States
- Employees
- CRVS N/A
- IHRT N/A
- Industry
- CRVS Biotechnology: Pharmaceutical Preparations
- IHRT Broadcasting
- Sector
- CRVS Health Care
- IHRT Consumer Discretionary
- Exchange
- CRVS Nasdaq
- IHRT Nasdaq
- Market Cap
- CRVS 305.4M
- IHRT 292.3M
- IPO Year
- CRVS 2016
- IHRT 2019
- Fundamental
- Price
- CRVS $4.10
- IHRT $1.81
- Analyst Decision
- CRVS Strong Buy
- IHRT Buy
- Analyst Count
- CRVS 4
- IHRT 3
- Target Price
- CRVS $15.00
- IHRT $2.92
- AVG Volume (30 Days)
- CRVS 445.0K
- IHRT 373.2K
- Earning Date
- CRVS 08-12-2025
- IHRT 08-11-2025
- Dividend Yield
- CRVS N/A
- IHRT N/A
- EPS Growth
- CRVS N/A
- IHRT N/A
- EPS
- CRVS N/A
- IHRT N/A
- Revenue
- CRVS N/A
- IHRT $3,862,595,000.00
- Revenue This Year
- CRVS N/A
- IHRT N/A
- Revenue Next Year
- CRVS N/A
- IHRT $5.89
- P/E Ratio
- CRVS N/A
- IHRT N/A
- Revenue Growth
- CRVS N/A
- IHRT 3.31
- 52 Week Low
- CRVS $2.47
- IHRT $0.95
- 52 Week High
- CRVS $10.00
- IHRT $2.84
- Technical
- Relative Strength Index (RSI)
- CRVS 44.93
- IHRT 45.12
- Support Level
- CRVS $4.58
- IHRT $1.91
- Resistance Level
- CRVS $4.98
- IHRT $2.00
- Average True Range (ATR)
- CRVS 0.23
- IHRT 0.09
- MACD
- CRVS -0.04
- IHRT -0.03
- Stochastic Oscillator
- CRVS 13.79
- IHRT 10.34
About CRVS Corvus Pharmaceuticals Inc.
Corvus Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing product candidates that precisely target proteins that are critical to immune cell maturation and function. Its product candidate, soquelitinib, is designed to bind specifically to a protein, interleukin 2 inducible T cell kinase (ITK), involved in T cell activation, T cell receptor signaling and T cell differentiation and function. The other products include Ciforadenant (CPI-444) and Mupadolimab (CPI-006).
About IHRT iHeartMedia Inc.
iHeartMedia Inc is a United States-based audio media company. The company operates through the segments of the Multiplatform Group, the Digital Audio Group, and the Audio & Media Services Group. The company derives prime revenue from the Multiplatform Group segment which includes the company's Broadcast radio, Networks and Sponsorships, and Events businesses. The Digital Audio Group segment includes all of the company's digital businesses, including podcasting; and the Audio & Media Services Group includes Katz Media Group, a full-service media representation business, and RCS Sound Software, a provider of scheduling and broadcast software and services.